Trial · NCT05568225
Results by group99
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 99
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Hematologic Improvement- Erythroid (HI-E) Response for >=8 Weeks Within 24 Weeks of Etavopivat Treatment | Non-transfusion Dependent | 0 | Percentage of participants | ||
| Percentage of Participants With Hematologic Improvement- Erythroid (HI-E) Response for >=8 Weeks Within 24 Weeks of Etavopivat Treatment | Low Transfusion Burden | 50 | Percentage of participants | ||
| Percentage of Participants With Hematologic Improvement- Erythroid (HI-E) Response for >=8 Weeks Within 24 Weeks of Etavopivat Treatment | High Transfusion Burden | 25 | Percentage of participants | ||
| Number of All Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs Related to Etavopivat | Non-transfusion Dependent | AE | 33 | Events | |
| Number of All Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs Related to Etavopivat | Low Transfusion Burden | AE | 33 | Events | |
| Number of All Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs Related to Etavopivat | High Transfusion Burden | AE | 54 | Events | |
| Number of All Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs Related to Etavopivat | Non-transfusion Dependent | SAE | 1 | Events | |
| Number of All Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs Related to Etavopivat | Low Transfusion Burden | SAE | 0 | Events | |
| Number of All Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs Related to Etavopivat | High Transfusion Burden | SAE | 6 | Events | |
| Number of All Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs Related to Etavopivat | Non-transfusion Dependent | AEs related to etavopivat | 0 | Events | |
| Number of All Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs Related to Etavopivat | Low Transfusion Burden | AEs related to etavopivat | 0 | Events | |
| Number of All Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs Related to Etavopivat | High Transfusion Burden | AEs related to etavopivat | 1 | Events | |
| Number of All Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs Related to Etavopivat | Non-transfusion Dependent | AEs possibly related etavopivat | 8 | Events | |
| Number of All Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs Related to Etavopivat | Low Transfusion Burden | AEs possibly related etavopivat | 3 | Events | |
| Number of All Adverse Events (AEs), Serious Adverse Events (SAEs), and AEs Related to Etavopivat | High Transfusion Burden | AEs possibly related etavopivat | 6 | Events | |
| Number of Premature Discontinuations, Dose Interruptions, and Dose Reductions | Non-transfusion Dependent | Premature discontinuations | 1 | Events | |
| Number of Premature Discontinuations, Dose Interruptions, and Dose Reductions | Low Transfusion Burden | Premature discontinuations | 0 | Events | |
| Number of Premature Discontinuations, Dose Interruptions, and Dose Reductions | High Transfusion Burden | Premature discontinuations | 0 | Events | |
| Number of Premature Discontinuations, Dose Interruptions, and Dose Reductions | Non-transfusion Dependent | Dose interruptions | 0 | Events | |
| Number of Premature Discontinuations, Dose Interruptions, and Dose Reductions | Low Transfusion Burden | Dose interruptions | 0 | Events |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05568225/results